The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study.
Xiaoqing YuJinfei SiJingwen WeiYanling WangYan SunJianan JinXiaoyan ZhangTonghui MaZhengbo SongPublished in: Cancer medicine (2022)
Advanced EGFR-mutant patients treated with EGFR-TKIs obtained absolute superior survival in the Chinese population.